Danske Bank A S Reduces Stock Position in Cencora, Inc. $COR

Danske Bank A S lowered its position in shares of Cencora, Inc. (NYSE:COR) by 10.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 274,384 shares of the company’s stock after selling 31,550 shares during the quarter. Danske Bank A S’s holdings in Cencora were worth $92,673,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Vestcor Inc boosted its position in Cencora by 0.5% during the 3rd quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after buying an additional 28 shares during the period. JFS Wealth Advisors LLC boosted its position in Cencora by 30.2% during the 4th quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after buying an additional 29 shares during the period. Cornerstone Wealth Group LLC boosted its position in Cencora by 1.3% during the 3rd quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock valued at $745,000 after buying an additional 30 shares during the period. Apollon Wealth Management LLC boosted its position in Cencora by 0.5% during the 4th quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after buying an additional 30 shares during the period. Finally, Vermillion & White Wealth Management Group LLC boosted its position in Cencora by 31.4% during the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $43,000 after buying an additional 33 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Trading Down 1.1%

NYSE:COR opened at $307.90 on Friday. The company has a 50-day moving average price of $333.36 and a 200-day moving average price of $342.95. Cencora, Inc. has a 12 month low of $271.00 and a 12 month high of $377.54. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a market cap of $59.90 billion, a price-to-earnings ratio of 37.01, a P/E/G ratio of 1.45 and a beta of 0.72.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period last year, the company posted $3.73 EPS. Equities analysts predict that Cencora, Inc. will post 17.56 EPS for the current year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is presently 28.85%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Bank of America dropped their target price on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research report on Monday, January 5th. Barclays raised their target price on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Jefferies Financial Group raised shares of Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. Finally, JPMorgan Chase & Co. raised their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $398.17.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.